KYLE PARTON: Open Payments
NPI 1619321262 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 46 payments from 10 companies in 2025. Trend: 2023 $442 · 2024 $589 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $242 |
| Novo Nordisk Inc | 12 | $163 |
| Lilly USA, LLC | 7 | $130 |
| PFIZER INC. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: VRAYLAR, Ozempic, PREVNAR 20, MOUNJARO, QULIPTA, JARDIANCE, Wegovy, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
